October 7, 2013 Issue | Chemical & Engineering News
 
Copyright © 2013 American Chemical Society
 

October 7, 2013 Issue

Volume 91, Issue 40
09140-cover-BiopharmaProduktionKundlcxd
October 7, 2013 Issue, Vol. 91 | Iss. 40
Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how
By Ann M. Thayer
(pp. 15-23)
Features
Business
Companies from East and West brace for an era of regulatory reform (pp. 26-30)
Science & Technology
ACS Meeting News: Advances in semiconductor and organic light-emitting diodes could lead to more-efficient lighting (pp. 46-49)
Back Issues
 

News of the Week

Merck To Slash Thousands Of Jobs

Pharmaceuticals: R&D takes new hit, and firm shifts headquarters
(p.9)

Destroying Syria’s Chemical Weapons

Arms Control: Goal is to eliminate Syrian arsenal by the middle of 2014
(p.10)

Revised Atomic Weights

Standards: Updates of 19 elements foreshadow change to the kilogram
(p.10)

Federal Helium Reserve Remains Open

Legislation: President Obama signed a bill to keep the facility operating
(p.11)

Shutdown Slams Federal R&D

Government: Budget impasse halts work for most government researchers and agencies
(p.11)

Carbon Fiber Makers Merge

Materials: Japan’s Toray, seeking expansion, will buy U.S. firm Zoltek for $584 million
(p.12)

Catalyst Calls The Shots

Organic Synthesis: Iron-based catalyst controls selectivity in C–H oxidations
(p.12)

California's Safer Consumer Products Initiative Kicks In

State to push consumer product makers to use safer ingredients whenever possible
(p.13)

Global Warming Affirmations

Environment: Latest world report rests on stronger science, researchers say
(p.13)
 

Departments

09140-bus3-Wolfgrubercxd

Business

German specialties firm targets U.S. market for growth
(pp. 38-39)
Firm hopes a move to Europe’s largest biotech community, Cambridge, will boost its anemic drug pipeline
(pp. 32-35)
Companies from East and West brace for an era of regulatory reform
(pp. 26-30)
Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how
(pp. 15-23)

Books

Humans have damaged all of Earth’s ecosystems; author argues that a new ethos toward nature is needed
(pp. 56-57)